Literature DB >> 26599286

Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Anand S Iyer1, Surya P Bhatt1, Jeffrey J Garner1, J Michael Wells1,2, Jennifer L Trevor1,2, Neha M Patel1, deNay Kirkpatrick1, John C Williams1, Mark T Dransfield1,2.   

Abstract

RATIONALE: Hospitalization for acute exacerbation of chronic obstructive pulmonary disease (COPD) is associated with significant morbidity and health care costs, and hospitals in the United States are now penalized by the Centers for Medicare and Medicaid Services for excessive readmissions. Identifying patients at risk of readmission is important, but modifiable risk factors have not been clearly established, and the potential contributing role of psychological disease has not been examined adequately. We hypothesized that depression and anxiety would increase the risk of both short- and long-term readmissions for acute exacerbation of COPD.
OBJECTIVES: To characterize the associations between depression and anxiety and COPD readmission risk.
METHODS: We examined the medical records for all patients with a primary diagnosis of acute exacerbation of COPD by International Classification of Diseases, Ninth Revision codes admitted to the University of Alabama at Birmingham Hospital between November 2010 and October 2012. Those who did not meet the standardized study criteria for acute exacerbation of COPD and those with other respiratory illnesses as the primary diagnosis were excluded. Comorbidities were recorded on the basis of physician documentation of the diagnosis and/or the use of medications in the electronic medical record. Multivariable regression analyses identified factors associated with readmission for acute exacerbation of COPD at 1 year and within 30 and 90 days.
MEASUREMENTS AND MAIN RESULTS: Four hundred twenty-two patients were included, with 132 readmitted in 1 year. Mean age was 64.8 ± 11.7 years, and mean percent predicted FEV1 was 48.1 ± 18.7%. On univariate analysis, readmitted patients had lower percent predicted FEV1 (44.9 ± 17.3% vs. 50.2 ± 19.4%; P = 0.05) and a higher frequency of depression (47.7% vs. 23.4%; P < 0.001). On multivariable analysis, 1-year readmission was independently associated with depression (adjusted odds ratio [OR], 2.67; 95% confidence interval [CI], 1.59-4.47) and in-hospital tobacco cessation counseling (adjusted OR, 0.34; 95% CI, 0.18-0.66). Depression also predicted readmission at 30 days (adjusted OR, 3.83; 95% CI, 1.84-7.96) and 90 days (adjusted OR, 2.47; 95% CI, 1.34-4.55).
CONCLUSIONS: Depression is an independent risk factor for both short- and long-term readmissions for acute exacerbation of COPD and may represent a modifiable risk factor. In-hospital tobacco cessation counseling was also associated with reduced 1-year readmission.

Entities:  

Keywords:  chronic obstructive pulmonary disease; depression; exacerbations; risk

Mesh:

Year:  2016        PMID: 26599286      PMCID: PMC5461954          DOI: 10.1513/AnnalsATS.201507-439OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  55 in total

Review 1.  Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes.

Authors:  A M Yohannes; G S Alexopoulos
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

2.  Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire.

Authors:  Kazuto Takada; Shuuichi Matsumoto; Eiji Kojima; Susumu Iwata; Shoutarou Okachi; Kiyoko Ninomiya; Hiroshi Morioka; Kentarou Tanaka; Yasunori Enomoto
Journal:  Respir Med       Date:  2011-03-30       Impact factor: 3.415

3.  Understanding why patients with COPD get readmitted: a large national study to delineate the Medicare population for the readmissions penalty expansion.

Authors:  Tina Shah; Matthew M Churpek; Marcelo Coca Perraillon; R Tamara Konetzka
Journal:  Chest       Date:  2015-05       Impact factor: 9.410

4.  Complex chronic comorbidities of COPD.

Authors:  L M Fabbri; F Luppi; B Beghé; K F Rabe
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

5.  Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jingjing Qian; Linda Simoni-Wastila; Gail B Rattinger; Ilene H Zuckerman; Susan Lehmann; Yu-Jung J Wei; Bruce Stuart
Journal:  Int J Geriatr Psychiatry       Date:  2013-04-19       Impact factor: 3.485

6.  Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease.

Authors:  Vincent S Fan; Scott D Ramsey; Nicholas D Giardino; Barry J Make; Charles F Emery; Phillip T Diaz; Joshua O Benditt; Zab Mosenifar; Robert McKenna; Jeffrey L Curtis; Alfred P Fishman; Fernando J Martinez
Journal:  Arch Intern Med       Date:  2007-11-26

7.  Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study.

Authors:  Peter A Coventry; Isla Gemmell; Christopher J Todd
Journal:  BMC Pulm Med       Date:  2011-11-04       Impact factor: 3.317

8.  The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study.

Authors:  Sigrun Alba Johannesdottir Schmidt; Martin Berg Johansen; Morten Olsen; Xiao Xu; Joseph M Parker; Nestor A Molfino; Timothy L Lash; Henrik Toft Sørensen; Christian Fynbo Christiansen
Journal:  BMJ Open       Date:  2014-12-19       Impact factor: 2.692

9.  Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.

Authors:  Anant R C Patel; Beverly S Kowlessar; Gavin C Donaldson; Alex J Mackay; Richa Singh; Siobhan N George; Davinder S Garcha; Jadwiga A Wedzicha; John R Hurst
Journal:  Am J Respir Crit Care Med       Date:  2013-11-01       Impact factor: 21.405

10.  Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort.

Authors:  Carlos H Martinez; Yuka Okajima; Susan Murray; George R Washko; Fernando J Martinez; Edwin K Silverman; Jin Hwa Lee; Elizabeth A Regan; James D Crapo; Jeffrey L Curtis; Hiroto Hatabu; MeiLan K Han
Journal:  Respir Res       Date:  2014-06-03
View more
  29 in total

1.  Factors Related to 30-day Readmission following Hospitalization for Any Medical Reason among Patients with Mental Disorders: Facteurs liés à la réhospitalisation à 30 jours suivant une hospitalisation pour une raison médicale chez des patients souffrant de troubles mentaux.

Authors:  Lia Gentil; Guy Grenier; Marie-Josée Fleury
Journal:  Can J Psychiatry       Date:  2020-10-16       Impact factor: 4.356

2.  Results of a Medicare Bundled Payments for Care Improvement Initiative for Chronic Obstructive Pulmonary Disease Readmissions.

Authors:  Surya P Bhatt; J Michael Wells; Anand S Iyer; deNay P Kirkpatrick; Trisha M Parekh; Lauren T Leach; Erica M Anderson; J Greg Sanders; Jessica K Nichols; Cindy C Blackburn; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2017-05

3.  Association of Guideline-Recommended COPD Inhaler Regimens With Mortality, Respiratory Exacerbations, and Quality of Life: A Secondary Analysis of the Long-Term Oxygen Treatment Trial.

Authors:  Thomas Keller; Laura J Spece; Lucas M Donovan; Edmunds Udris; Scott S Coggeshall; Matthew Griffith; Alexander D Bryant; Richard Casaburi; J Allen Cooper; Gerard J Criner; Philip T Diaz; Anne L Fuhlbrigge; Steven E Gay; Richard E Kanner; Fernando J Martinez; Ralph J Panos; David Shade; Alice Sternberg; Thomas Stibolt; James K Stoller; James Tonascia; Robert Wise; Roger D Yusen; David H Au; Laura C Feemster
Journal:  Chest       Date:  2020-04-09       Impact factor: 9.410

4.  Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.

Authors:  Priti Poojary; Aparna Saha; Kinsuk Chauhan; Priya Simoes; Bruce E Sands; Judy Cho; Thomas Ullman; Girish Nadkarni; Ryan Ungaro
Journal:  Inflamm Bowel Dis       Date:  2017-03       Impact factor: 5.325

Review 5.  Benefit-Risk Assessment of Psychotropic Drugs in Older Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Abebaw Mengistu Yohannes; Jeff W Jin; Mark E Kunik
Journal:  Drugs Aging       Date:  2022-04-19       Impact factor: 3.923

6.  Risks of Benzodiazepines in Chronic Obstructive Pulmonary Disease with Comorbid Posttraumatic Stress Disorder.

Authors:  Lucas M Donovan; Carol A Malte; Laura J Spece; Matthew F Griffith; Laura C Feemster; Ruth A Engelberg; David H Au; Eric J Hawkins
Journal:  Ann Am Thorac Soc       Date:  2019-01

7.  A Qualitative Study of Pulmonary and Palliative Care Clinician Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; James Nicholas Dionne-Odom; Dina M Khateeb; Lanier O'Hare; Rodney O Tucker; Cynthia J Brown; Mark T Dransfield; Marie A Bakitas
Journal:  J Palliat Med       Date:  2019-10-29       Impact factor: 2.947

8.  Multimorbidity, frailty and chronic obstructive pulmonary disease: Are the challenges for pulmonary rehabilitation in the name?

Authors:  Anne E Holland; Samantha L Harrison; Dina Brooks
Journal:  Chron Respir Dis       Date:  2016-10-26       Impact factor: 2.444

Review 9.  COPD Readmissions: Addressing COPD in the Era of Value-based Health Care.

Authors:  Tina Shah; Valerie G Press; Megan Huisingh-Scheetz; Steven R White
Journal:  Chest       Date:  2016-05-07       Impact factor: 9.410

10.  Comorbid Anxiety and Depression, Though Underdiagnosed, Are Not Associated with High Rates of Low-Value Care in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Matthew F Griffith; Hung-Yuan P Chen; David B Bekelman; Laura C Feemster; Laura J Spece; Lucas M Donovan; David H Au; Evan P Carey
Journal:  Ann Am Thorac Soc       Date:  2021-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.